Pricing Log in Create free account

Atossa Therapeutics, Inc. (ATOS) vs Celyad SA (CYAD)

Atossa Therapeutics, Inc. and Celyad SA are both Biotechnology companies. Atossa Therapeutics, Inc. is the larger, with a market value of $26.4M against $23.8M — 1.1× the size. Across the 9 metrics below, Celyad SA leads on 5 and Atossa Therapeutics, Inc. on 4.

Valuation

Metric ATOS CYAD Biotechnology median
P/E n/m n/m 8.50
P/S 646.51 n/m 9.71
P/B 0.97 11.18 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.01 — 0.64
EV/Sales (6.95) — 9.21
Earnings yield (150.60%) (708.87%) (33.15%)
Free cash flow yield (138.09%) (438.06%) (25.50%)

Profitability

Metric ATOS CYAD Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (89.23%) 0.00% (56.36%)
Return on assets (77.91%) 0.00% (48.04%)
Return on invested capital (3,918.83%) 0.00% 0.00%

Growth

Metric ATOS CYAD Biotechnology median
Revenue growth (TTM) (93.66%) — 6.02%
EPS growth (last fiscal year) (34.73%) 113.33% 30.26%
Revenue growth, 5-year CAGR — (63.51%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATOS CYAD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.69 0.94 4.72
Net debt to EBITDA 1.12 (1.62) 0.96

Dividend

Metric ATOS CYAD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ATOS CYAD Biotechnology median
Market cap 26.44m 23.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack